VRXA — Veraxa Biotech AG Share News
0.000.00%
- $147.73m
- $147.70m
Brief: Veraxa Biotech Shareholders Approve All Proposals At Extraordinary General Meeting, Strengthening Strategic Flexibility For Future Growth
Brief: Veraxa Biotech Initiates Cell Line Development With ATUM
NASDAQ RESUMED AT 01:08 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
NASDAQ RESUMED AT 11:22 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:57 AM
NASDAQ RESUMED AT 11:24 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:17 AM
NASDAQ RESUMED AT 11:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:49 AM
NASDAQ RESUMED AT 10:41 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:34 AM
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:04 AM
NASDAQ RESUMED AT 10:03 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:52 AM
NASDAQ RESUMED AT 09:52 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:40 AM
NASDAQ RESUMED AT 09:40 AM